Absorption of papaverine, la-danosme and cepharanthine across human intestine by using human Caco-2 cells monolayers model

Yaoxue Xuebao

Volumn 43, Issue 2, 2008, Pages 202-207

  Ma, Lian ^a   Yang, Xiu Wei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Apparent permeability coefficient; Caco 2 cell monolayer; Cepharanthine; Intestinal absorption; Laudanosine; Papaverine

Indexed keywords

BENZYLISOQUINOLINE DERIVATIVE; CEPHARANTHINE; ISOQUINOLINE DERIVATIVE; LAUDANOSINE; PAPAVERINE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMISTRY; EPITHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE ABSORPTION; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; METHODOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

BENZYLISOQUINOLINES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITHELIAL CELLS; HUMANS; INTESTINAL ABSORPTION; ISOQUINOLINES; PAPAVERINE; PLANTS, MEDICINAL;

EID: 42149166074     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yang XW, Yang XD, Pu XP, et al. Establishing of studying platform of the drug ' s absorption, distribution, metabolism, excretion and toxicity (ADME/Tox.) [J]. J Peking Univer (Health Sci). 2004,36:5 - 8.
2. Yang XW. Discovery strategy for effective and active constituents of Chinese material medica based on the processes of metabolism and disposition in intra-body [J]. China J Chin Mater Med, 2007, 32:365 - 370.
3. Yang XW. Discovery strategy for toxic-invited constituents and toxic-effective substances on Chinese material medica based on the processes of metabolism and disposition in intra-body [J]. China J Tradi Chin Med Pharm, 2007,22:67-72.
4. Yang XW, Yang XD, Wang Y, et al. Establishment of Caco-2 cell model and the standard operation procedure for assessing intestinal absorption of chemical components of traditional Chinese medicine [J]. J Chin Integr Med, 2007,5:634 - 641.
5. Yang XW. Absorption, Distribution, Metabolism, Excretion, Toxicity and Activity of the Chemical Constituents in Traditional Chinese Medicines [M]. Beijing: China Medico-Pharmaceutical Science Technology Publishing House, 2006:1449 - 1452,1458 - 1462.
6. Tian L, Yang XW, Wang Y, et al. Characteristics of uptake, transport and efflux of Z- and E- ajoenes in Caco2 cell monolayers in vitro [J]. Acta Pharm Sin, 2007,42:87-92.
7. Yee SY. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth [J]. Pharm Res, 1997, 14:763 - 766.
8. Chong S, Dando SA, Morrison RA. Evaluation of biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity [J]. Pharm Res, 1997,14: 1835 - 1837.
9. Gao JN, Hugger ED, Beck-Westermeyer MS, et al. Estimating intestinal mucosal permeation of compounds using Caco -2 cell monolayer [M]//Enna SJ. Current Protocols in Pharmacology. Chichester: John Wiley & Sons Inc., 2000:7.2. 1 - 7.2. 23.
10. Walle UK, French KL, Walgren RA, et al. Transport of genistein-7- glucoside by human intestinal Caco-2 cells; potential role for MRP2 [J]. Res Comm Mol Pathol Pharmacol, 1999,103:45 - 56.
11. Czarnecki W, Wielgus S. Effect of carriers and hydrophilic agents on papaverine spheres bioavailability [J]. Acta Pol Pharm, 1996,53:337 - 340.
12. Kraus C, Shaaya A, Ulmer J, et al. Pharmacokinetics and bioavailability of papaverine HCl following intravenous, peroral, rectal, vaginal, topical and buccal administration in beagle dogs [J]. Biopharm Drug Dispos, 1991,12:537 - 546.
13. Berg G, Jonsson KA, Hammar M, et al, Variable bioavailability of papaverine [J]. Pharmacol Toxicol, 1998,62:308-310.
14. Melloni GF, Melloni R. Papaverine bioavailability in delayed absorption formulations [J]. Boll Soc Ital Biol Sper, 1981,57:1489 - 1495.